43 related articles for article (PubMed ID: 38680297)
1. Abemaciclib pharmacology and interactions in the treatment of HR+/HER2- breast cancer: a critical review.
Martorana F; Sanò MV; Valerio MR; Fogli S; Vigneri P; Danesi R; Gebbia V
Ther Adv Drug Saf; 2024; 15():20420986231224214. PubMed ID: 38665218
[TBL] [Abstract][Full Text] [Related]
2. PDA-Based Drug Delivery Nanosystems: A Potential Approach for Glioma Treatment.
Wu H; Wei M; Xu Y; Li Y; Zhai X; Su P; Ma Q; Zhang H
Int J Nanomedicine; 2022; 17():3751-3775. PubMed ID: 36065287
[TBL] [Abstract][Full Text] [Related]
3. Lysine-Polydopamine Nanocrystals Loaded with the Codrug Abemaciclib-Flurbiprofen for Oral Treatment of Cancer.
Sun T; Zhang F; Xu Y; Wang X; Jia J; Sang L; Li J; Wang D; Yu Z
ACS Omega; 2024 Apr; 9(16):18137-18147. PubMed ID: 38680297
[TBL] [Abstract][Full Text] [Related]
4. A novel electrospun nanofiber system with PEGylated paclitaxel nanocrystals enhancing the transmucus permeability and in situ retention for an efficient cervicovaginal cancer therapy.
Duan H; Chen H; Qi C; Lv F; Wang J; Liu Y; Liu Z; Liu Y
Int J Pharm; 2024 Jan; 650():123660. PubMed ID: 38072148
[TBL] [Abstract][Full Text] [Related]
5. Polydopamine-coated thalidomide nanocrystals promote DSS-induced murine colitis recovery through Macrophage M2 polarization together with the synergistic anti-inflammatory and anti-angiogenic effects.
Meng Z; Fu B; Yang Z; Xu Y; Huang H; Bai Y; Fang X; Shen S; Yang J; Yong J; Tao X; Ma C; Miao W; Ren H; Wang Y; Xu H; Li X
Int J Pharm; 2023 Jan; 630():122376. PubMed ID: 36400133
[TBL] [Abstract][Full Text] [Related]
6. Polydopamine Nanosphere with In-Situ Loaded Gentamicin and Its Antimicrobial Activity.
Batul R; Bhave M; J Mahon P; Yu A
Molecules; 2020 Apr; 25(9):. PubMed ID: 32365745
[TBL] [Abstract][Full Text] [Related]
7. Polydopamine surface-modified hyperbranched polymeric nanoparticles for synergistic chemo/photothermal therapy of oral cancer.
Yin X; Li Z; Zhang Y; Zeng X; Wang Q; Liang Z
Front Bioeng Biotechnol; 2023; 11():1174014. PubMed ID: 37214280
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes.
Chen M; Li W; Zhang X; Dong Y; Hua Y; Zhang H; Gao J; Zhao L; Li Y; Zheng A
Int J Nanomedicine; 2017; 12():5487-5500. PubMed ID: 28814865
[TBL] [Abstract][Full Text] [Related]
9. Theranostics platform of Abemaciclib using magnetite@silica@chitosan nanocomposite.
El-Shahawy AAG; Zohery M; El-Dek SI
Int J Biol Macromol; 2022 Nov; 221():634-643. PubMed ID: 36087748
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in combretastatin A-4 codrugs for cancer therapy.
Guo K; Ma X; Li J; Zhang C; Wu L
Eur J Med Chem; 2022 Nov; 241():114660. PubMed ID: 35964428
[TBL] [Abstract][Full Text] [Related]
11. Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment.
Thoma OM; Neurath MF; Waldner MJ
Front Pharmacol; 2021; 12():757120. PubMed ID: 35002699
[TBL] [Abstract][Full Text] [Related]
12. Nanocrystals for Improving Oral Bioavailability of Drugs: Intestinal Transport Mechanisms and Influencing Factors.
Tian Z; Mai Y; Meng T; Ma S; Gou G; Yang J
AAPS PharmSciTech; 2021 Jun; 22(5):179. PubMed ID: 34128132
[TBL] [Abstract][Full Text] [Related]
13. The inflammatory pathogenesis of colorectal cancer.
Schmitt M; Greten FR
Nat Rev Immunol; 2021 Oct; 21(10):653-667. PubMed ID: 33911231
[TBL] [Abstract][Full Text] [Related]
14. Prediction of severe neutropenia and diarrhoea in breast cancer patients treated with abemaciclib.
Modi ND; Abuhelwa AY; Badaoui S; Shaw E; Shankaran K; McKinnon RA; Rowland A; Sorich MJ; Hopkins AM
Breast; 2021 Aug; 58():57-62. PubMed ID: 33906086
[TBL] [Abstract][Full Text] [Related]
15. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020.
Cao W; Chen HD; Yu YW; Li N; Chen WQ
Chin Med J (Engl); 2021 Mar; 134(7):783-791. PubMed ID: 33734139
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
